![Repligen Corporation logo](/logos/RGEN.webp)
Repligen Corporation
NASDAQ:RGEN
Overview | Financials
Company Name | Repligen Corporation |
Symbol | RGEN |
Currency | USD |
Price | 147.07 |
Market Cap | 8,236,875,955 |
Dividend Yield | 0% |
52-week-range | 110.45 - 211.13 |
Industry | Medical Instruments & Supplies |
Sector | Healthcare |
CEO | Mr. Anthony J. Hunt |
Website | https://www.repligen.com |
An error occurred while fetching data.
About Repligen Corporation
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD